Financial Publications
Capital Market Release
PTA-PVR: Dr. Hönle AG: Release according to Article 40, Section 1 of the WpHG
07.08.2024
Gilching (pta022/07.08.2024/16:10) - Release of Voting Rights Announcement
read more ...
PTA-PVR: Dr. Hönle AG: Release according to Article 40, Section 1 of the WpHG
07.08.2024
Gilching (pta020/07.08.2024/16:05) - Release of Voting Rights Announcement
read more ...
PTA-News: Dr. Hönle AG: Hönle achieves almost balanced operating result in a challenging market environment after 9 months
07.08.2024
Gilching (pta006/07.08.2024/08:40) - - Sales of €72.1 million are 9.6% below the previous year's figures
read more ...
PTA-News: Dr. Hönle AG: Robert Stark set to be new CFO of Dr. Hönle AG
06.08.2024
Gilching (pta021/06.08.2024/11:25) - On 2 August 2024, the Supervisory Board of Dr. Hönle AG appointed Robert Stark as a member of the Management Board of Dr. Hönle AG effective 1 October 2024. Robert Stark will assume the post of Chief Financial Officer. Dr. Markus Arendt was appointed...
read more ...
PTA-News: Dr. Hönle AG: Sales and results in the first half of the year below the previous year in a challenging market environment
08.05.2024
Gilching (pta009/08.05.2024/08:10) - * Weakness in machinery and plant engineering and project postponements in the solar industry and electromobility business lead to a 10.1% decline in sales to € 48.1 million * Operating result is € –0.1 million after € 3.7 million in the...
read more ...
PTA-News: Dr. Hönle AG: Markus Arendt takes up his position as CEO of Dr. Hönle AG
07.05.2024
Gilching (pta010/07.05.2024/08:55) - As planned, Dr. Markus Arendt took up his position as CEO of Dr. Hönle AG on May 1, 2024. He succeeds Dr. Franz Richter, who was appointed to the Executive Board by the Supervisory Board for a year. Franz Richter returns to the Supervisory Board and...
read more ...
PTA-AFR: Dr. Hönle AG: Pre-announcement of a financial report according to articles 114 - 117 WpHG
18.04.2024
Gilching (pta028/18.04.2024/15:30) - Dr. Hönle AG announces that the following financial reports shall be disclosed:
read more ...
PTA-PVR: Dr. Hönle AG: Release according to Article 40, Section 1 of the WpHG
27.02.2024
Gilching (pta019/27.02.2024/10:45) - Release of Voting Rights Announcement
read more ...
PTA-News: Dr. Hönle AG: Hönle Group has a moderate start to the new financial year and confirms the outlook for the year as a whole
26.02.2024
Gilching (pta006/26.02.2024/07:55) - * Revenue in the first quarter of €23.8 million below the previous year's figure of €27.6 million due to the weak market environment * Operating result of € -0.8 million after € 1.9 million in the previous year * Positive operating cash flow of...
read more ...
PTA-PVR: Dr. Hönle AG: Release according to Article 40, Section 1 of the WpHG
23.02.2024
Gilching (pta025/23.02.2024/14:19) - Release of Voting Rights Announcement
read more ...
PTA-PVR: Dr. Hönle AG: Release according to Article 40, Section 1 of the WpHG
23.02.2024
Gilching (pta019/23.02.2024/12:49) - Release of Voting Rights Announcement
read more ...
PTA-DD: Dr. Hönle AG: Managers' transactions announcement according to article 19 MAR
22.02.2024
Gilching (pta023/22.02.2024/13:00) - Announcement
read more ...
PTA-DD: Dr. Hönle AG: Managers' transactions announcement according to article 19 MAR
22.02.2024
Gilching (pta025/22.02.2024/13:00) - Announcement
read more ...
PTA-DD: Dr. Hönle AG: Managers' transactions announcement according to article 19 MAR
22.02.2024
Gilching (pta027/22.02.2024/13:00) - Announcement
read more ...
PTA-PVR: Dr. Hönle AG: Release according to Article 40, Section 1 of the WpHG
15.02.2024
Gilching (pta028/15.02.2024/15:55) - Release of Voting Rights Announcement
read more ...
PTA-News: Dr. Hönle AG: Hönle Group generated adjusted operating profit of €6.9 million in the 2022/2023 financial year
07.12.2023
Gilching (pta036/07.12.2023/17:50) - According to preliminary figures, the Hönle Group achieved sales of €106.3 million in the 2022/2023 financial year (previous year: €116.1 million from continuing operations). Sales are therefore above the previously communicated target range of...
read more ...
PTA-AFR: Dr. Hönle AG: Pre-announcement of a financial report according to articles 114 - 117 WpHG
03.11.2023
Gilching (pta015/03.11.2023/11:45) - Dr. Hönle AG announces that the following financial reports shall be disclosed:
read more ...
PTA-News: Dr. Hönle AG: Dr. Markus Arendt becomes Managing Director of Dr. Hönle AG
20.10.2023
Gilching (pta026/20.10.2023/18:30) - The Supervisory Board of Dr. Hönle AG intends to appoint Dr. Markus Arendt as a member of the Management Board of Dr. Hönle AG with effect presumably from May 1st, 2024. He will follow Dr. Franz Richter, who was delegated to the Management Board by...
read more ...
PTA-News: Dr. Hönle AG: Hönle generated an adjusted operating result of €5.0 million in nine months
07.08.2023
Gilching (pta011/07.08.2023/08:30) - * Still high order backlog * Revenue decreases by 8.5% to €79.7 million due to a drop in revenue in the air sterilization sector * Discontinuation of the product line of mobile air disinfection systems and the resignation of a member of the...
read more ...
PTA-PVR: Dr. Hönle AG: Release according to Article 40, Section 1 of the WpHG
30.06.2023
Gilching (pta013/30.06.2023/09:20) - Release of Voting Rights Announcement
read more ...
PTA-DD: Dr. Hönle AG: Managers' transactions announcement according to article 19 MAR
12.06.2023
Gilching (pta025/12.06.2023/11:20) - Announcement
read more ...
PTA-DD: Dr. Hönle AG: Managers' transactions announcement according to article 19 MAR
07.06.2023
Gilching (pta052/07.06.2023/17:30) - Announcement
read more ...
PTA-DD: Dr. Hönle AG: Managers' transactions announcement according to article 19 MAR
07.06.2023
Gilching (pta050/07.06.2023/17:25) - Announcement
read more ...
PTA-DD: Dr. Hönle AG: Managers' transactions announcement according to article 19 MAR
07.06.2023
Gilching (pta048/07.06.2023/17:20) - Announcement
read more ...
PTA-DD: Dr. Hönle AG: Managers' transactions announcement according to article 19 MAR
07.06.2023
Gilching (pta036/07.06.2023/17:10) - Announcement
read more ...
PTA-PVR: Dr. Hönle AG: Release according to Article 40, Section 1 of the WpHG
07.06.2023
Gilching (pta034/07.06.2023/16:45) - Release of Voting Rights Announcement
read more ...
PTA-News: Dr. Hönle AG: Hönle generated an operating result of €3.7 million in the first six months
12.05.2023
Gilching (pta009/12.05.2023/08:20) - At T€ 53,520 sales revenues generated by the Hönle Group in the first six months of financial year 2022/2023 were below the prior year's figure of T€ 60,807. The decline is mainly due to the air disinfection business, in which sales decreased by...
read more ...
PTA-News: Dr. Hönle AG: Change at the top of Dr. Hönle AG: Dr. Franz Richter becomes the new CEO
25.04.2023
Gilching (pta046/25.04.2023/23:40) - The Supervisory Board of Dr. Hönle AG delegates Dr. Franz Richter, who currently holds the position of Chairman of the Supervisory Board of Dr. Hönle AG, as the successor to the Chairman of the Management Board, Mr. Norbert Haimerl, who is resigning...
read more ...
PTA-News: Dr. Hönle AG: Dr. Franz Richter is the new Chairman of the Supervisory Board of Dr. Hönle AG
31.03.2023
Gilching (pta022/31.03.2023/09:55) - The Annual General Meeting has elected Dr. Franz Richter to the Supervisory Board of Dr. Hönle AG. Dr. Richter takes over the chairmanship of the supervisory board and thus succeeds Prof. Dr. Karl Hönle, who resigned from office with effect from the...
read more ...
PTA-DD: Dr. Hönle AG: Managers' transactions announcement according to article 19 MAR
15.02.2023
Gilching (pta019/15.02.2023/12:15) - Announcement
read more ...
PTA-PVR: Dr. Hönle AG: Release according to Article 40, Section 1 of the WpHG
17.01.2023
Gilching (pta010/17.01.2023/09:35) - Release of Voting Rights Announcement
read more ...
PTA-News: Dr. Hönle AG: Planned change in the supervisory board of Dr. Hönle AG
15.12.2022
Gilching (pta026/15.12.2022/14:00) - Prof. Dr. Karl Hönle, company founder and long-time chairman of the supervisory board of Dr. Hönle AG will resign from office at the next Annual General Meeting on March 23, 2023 and will be leaving the Supervisory Board at his own request. The...
read more ...
PTA-PVR: Dr. Hönle AG: Release according to Article 40, Section 1 of the WpHG
09.12.2022
Gilching (pta022/09.12.2022/15:24) - Release of Voting Rights Announcement
read more ...
PTA-AFR: Dr. Hönle AG: Pre-announcement of a financial report according to articles 114 - 117 WpHG
19.10.2022
Gilching (pta021/19.10.2022/14:02) - Dr. Hönle AG announces that the following financial reports shall be disclosed:
read more ...
PTA-PVR : Dr. Hönle AG: Release according to Article 40, Section 1 of the WpHG
02.09.2022
Gilching (pta024/02.09.2022/12:00) - Release of Voting Rights Announcement
read more ...
PTA-DD: Dr. Hönle AG: Managers' transactions announcement according to article 19 MAR
02.09.2022
Gilching (pta019/02.09.2022/11:05) - Announcement
read more ...
PTA-News: Dr. Hönle AG: Hönle Group increases sales by 12% in 9 months
05.08.2022
Gilching (pta009/05.08.2022/08:00) - Sales revenues generated by the Hönle Group rose by 12% to T€ 95,141 in the first nine months of financial year 2021/2022 compared with the prior-year period.
read more ...
PTA-News: Dr. Hönle AG: Restructuring of the Management Board of Dr. Hönle AG
16.05.2022
Gilching (pta026/16.05.2022/11:45) - The supervisory board of Dr. Hönle AG has decided to restructure the Management Board of Dr. Hönle AG.
read more ...
PTA-News: Dr. Hönle AG: Hönle increases its operating result by 14% to € 7.7 million in six months
12.05.2022
Gilching (pta006/12.05.2022/08:00) - The economic recovery impacted positively on the Hönle Group's course of business. Both incoming orders and order backlog were clearly above the prior year's level. An even higher rise in revenue failed to realise due to long delivery times concerning...
read more ...
PTA-AFR: Dr. Hönle AG: Pre-announcement of a financial report according to articles 114 - 117 WpHG
11.05.2022
Gilching (pta043/11.05.2022/19:30) - Dr. Hönle AG announces that the following financial reports shall be disclosed:
read more ...
PTA-DD: Dr. Hönle AG: Managers' transactions announcement according to article 19 MAR
31.03.2022
Gilching (pta104/31.03.2022/15:35) - Announcement
read more ...
PTA-PVR : Dr. Hönle AG: Correction of a Release according to article 40 para. 1 WpHG from 28.02.2022
23.03.2022
Gilching (pta031/23.03.2022/14:30) - Release of Voting Rights Announcement
read more ...
PTA-PVR : Dr. Hönle AG: Correction of a Release according to article 40 para. 1 WpHG from 28.02.2022
28.02.2022
Gilching (pta043/28.02.2022/15:30) - Release of Voting Rights Announcement
read more ...
PTA-PVR : Dr. Hönle AG: Release according to Article 40, Section 1 of the WpHG
28.02.2022
Gilching (pta033/28.02.2022/14:40) - Release of Voting Rights Announcement
read more ...
PTA-PVR : Dr. Hönle AG: Release according to Article 40, Section 1 of the WpHG
24.02.2022
Gilching (pta015/24.02.2022/12:00) - Release of Voting Rights Announcement
read more ...
PTA-News: Dr. Hönle AG: Hönle increases its operating result by 113.6% to € 4.5 million in the first quarter
22.02.2022
Gilching (pta025/22.02.2022/11:00) - In the first quarter of financial year 2021/2022, the Hönle Group's revenues rose by 25.3% to T€ 33,418 compared to the prior year quarter. Both the Equipment & Systems and Glass & Lamps segments recorded significant revenue increases. A...
read more ...
PTA-DD: Dr. Hönle AG: Managers' transactions announcement according to article 19 MAR
26.10.2021
Gilching (pta013/26.10.2021/11:15) - Announcement
read more ...
PTA-News: Dr. Hönle AG: Sales increase in the 9-month period by 18.4% to EUR 84.9 million
06.08.2021
Gräfelfing/München (pta007/06.08.2021/08:05) - Revenues earned by the Hönle Group in the 9-month period climbed from T€ 71,734 in the previous year to T€ 84,932 in the current financial year. The following factors led to a slowdown in the Hönle Group's business development in the...
read more ...
PTA-DD: Dr. Hönle AG: Managers' transactions announcement according to article 19 MAR
01.07.2021
Graefelfing, Munich (pta031/01.07.2021/15:00) - Announcement
read more ...
PTA-News: Dr. Hönle AG: Hönle increases its operating result by 16.4% to EUR 6.7 million in the first half of the year
12.05.2021
Gräfelfing/München (pta011/12.05.2021/08:05) - Although the Hönle Group was still largely spared from the corona pandemic in the first half of the previous year, the reluctance to invest especially in the printing business was clearly felt in the current financial year. Nevertheless,...
read more ...
PTA-News: Dr. Hönle AG: Hönle achieves revenues of Euro 26.7 million and an operating result of Euro 2.1 million in the first quarter
22.02.2021
Gräfelfing, Munich (pta011/22.02.2021/08:00) - In particular, as a consequence of acquisitions, the Hönle Group's sales revenues increased by 4.6% to TEur 26,673 in the first quarter of financial year 2020/2021. With Sterilsystems GmbH, based in Austria, Hönle acquired a company...
read more ...
PTA-AFR: Dr. Hönle AG: Pre-announcement of a financial report according to articles 114 - 117 WpHG
12.02.2021
Graefelfing, Munich (pta014/12.02.2021/10:45) - Dr. Hönle AG announces that the following financial reports shall be disclosed:
read more ...
PTA-News: Dr. Hönle AG: Hönle Group generates operating profit of EUR 8.1 million
02.12.2020
Gräfelfing/München (pta009/02.12.2020/07:40) - From spring 2020, the business development of the Hönle Group was increasingly influenced by the effects of the global corona pandemic. According to preliminary figures, sales in the 2019/2020 financial year were therefore Eur 93.9 million...
read more ...
PTA-NVR: Dr. Hönle AG: Total Voting Rights Announcement according to Article 41 of the WpHG
01.09.2020
Graefelfing, Munich (pta027/01.09.2020/15:05) - Publication
read more ...
PTA-News: Dr. Hönle AG: Acquisition in the Life Science Sector
18.08.2020
Gräfelfing/München (pta030/18.08.2020/16:05) - Dr. Hönle AG acquires STERILSYSTEMS GmbH. The Hönle Group is thus significantly expanding its activities in the life science sector. As a result of the pandemic, sensitivity to and global demand for disinfection solutions has risen...
read more ...
PTA-News: Dr. Hönle AG: Hönle achieves operating result of Euro 6.3 million
07.08.2020
Graefelfing (pta013/07.08.2020/07:40) - The Hönle Group generated sales revenues of TEur 71.734 in the first nine months of the financial year 2019/2020, which is 11.7% below the previous year's level. The operating result (EBIT) dropped from TEur 13,256 to TEur 6,287. The COVID 19...
read more ...
PTA-News: Dr. Hönle AG: Hönle Group generates operating result of 5.8 million euros
15.05.2020
Gräfelfing/München (pta008/15.05.2020/08:00) - The Hönle Group's sales in the first six months of the 2019/2020 financial year were Eur 50,853 thousand, 9.2% below the previous year's figure. The operating result fell by 43.2% to Eur 5,786 thousand. As in the previous year, a lower...
read more ...
PTA-DD: Dr. Hönle AG: Managers' transactions announcement according to article 19 MAR
30.03.2020
Graefelfing, Munich (pta009/30.03.2020/09:20) - Announcement
read more ...
PTA-PVR : Dr. Hönle AG: Release according to Article 40, Section 1 of the WpHG
06.03.2020
Graefelfing,Munich (pta017/06.03.2020/10:35) - Release of Voting Rights Announcement
read more ...
PTA-DD: Dr. Hönle AG: Managers' transactions announcement according to article 19 MAR
26.02.2020
Graefelfing, Munich (pta026/26.02.2020/17:50) - Announcement
read more ...
PTA-News: Dr. Hönle AG: Hönle Group generates operating result of 3.7 million euros
21.02.2020
Gräfelfing/München (pta007/21.02.2020/08:00) - Revenue earned by the Hönle Group declined from TEur 30,250 in the previous year to TEur 25,499 in the first quarter of financial year 2019/2020. In the previous year already, a significantly lower order volume with a major customer in the...
read more ...
PTA-PVR : Dr. Hönle AG: Release according to Article 40, Section 1 of the WpHG
07.02.2020
Graefelfing (pta016/07.02.2020/11:43) - Release of Voting Rights Announcement
read more ...
PTA-AFR: Dr. Hönle AG: Pre-announcement of a financial report according to articles 114 - 117 WpHG
09.01.2020
Graefelfing, Munich (pta023/09.01.2020/17:38) - Dr. Hönle AG announces that the following financial reports shall be disclosed:
read more ...
PTA-PVR : Dr. Hönle AG: Release according to Article 40, Section 1 of the WpHG
19.11.2019
Gräfelfing, Munich (pta042/19.11.2019/18:40) - Release of Voting Rights Announcement
read more ...
PTA-PVR : Dr. Hönle AG: Release according to Article 40, Section 1 of the WpHG
07.11.2019
Gräfelfing/München (pta021/07.11.2019/10:45) - Release of Voting Rights Announcement
read more ...
PTA-PVR : Dr. Hönle AG: Release according to Article 40, Section 1 of the WpHG
24.10.2019
Graefelfing, Munich (pta031/24.10.2019/18:30) - Release of Voting Rights Announcement
read more ...
PTA-PVR : Dr. Hönle AG: Release according to Article 40, Section 1 of the WpHG
22.10.2019
Graefelfing, Munich (pta012/22.10.2019/09:45) - Release of Voting Rights Announcement
read more ...
PTA-PVR : Dr. Hönle AG: Release according to Article 40, Section 1 of the WpHG
16.09.2019
Graefelfing, Munich (pta039/16.09.2019/17:30) - Release of Voting Rights Announcement
read more ...
PTA-PVR : Dr. Hönle AG: Release according to Article 40, Section 1 of the WpHG
28.08.2019
Gräfelfing (pta033/28.08.2019/13:30) - Release of Voting Rights Announcement
read more ...
PTA-News: Dr. Hönle AG: Hönle Group generates operating result of 13.3 million euros
09.08.2019
Gräfelfing/München (pta010/09.08.2019/08:30) - The Hönle Group's sales revenues came to TEur 81,240 in the nine-month period, which is 8.5% below the previous year's figure. The operating result (EBIT) decreased from TEur 19,865 to TEur 13,256, which translates into an EBIT margin of...
read more ...
PTA-PVR : Dr. Hönle AG: Release according to Article 40, Section 1 of the WpHG
02.08.2019
Graefelfing, Munich (pta021/02.08.2019/11:30) - Release of Voting Rights Announcement
read more ...
PTA-PVR : Dr. Hönle AG: Release according to Article 40, Section 1 of the WpHG
05.07.2019
Graefelfing (pta022/05.07.2019/13:50) - Release of Voting Rights Announcement
read more ...
PTA-PVR : Dr. Hönle AG: Release according to Article 40, Section 1 of the WpHG
25.06.2019
Graefelfing, Munich (pta026/25.06.2019/14:00) - Release of Voting Rights Announcement
read more ...
PTA-PVR : Dr. Hönle AG: Release according to Article 40, Section 1 of the WpHG
12.06.2019
Graefelfing, Munich (pta028/12.06.2019/14:25) - Release of Voting Rights Announcement
read more ...
PTA-News: Dr. Hönle AG: Hönle achieves an operating result of 10.2 million euros in the first six months
17.05.2019
Gräfelfing/München (pta009/17.05.2019/08:00) - The Hönle Group's sales revenues decreased by 7.7 % to TEur 55,990 in the first six months of the 2018/2019 financial year compared with the prior-year period. Owing to lower adhesives sales, the operating result (EBIT) decreased from TEur...
read more ...
PTA-News: Dr. Hönle AG: Hönle achieves an operating result of 6.6 million euros in the first quarter
22.02.2019
Graefelfing, Munich (pta011/22.02.2019/07:35) - Revenues of the Hönle Group in the first quarter of Eur 30,250 thousand were 2.4% higher than in the same period of the previous year. The operating result (EBIT) amounted to Eur 6,555 thousand (previous year: Eur 7,392 thousand). This...
read more ...
PTA-PVR : Dr. Hönle AG: Release according to Article 40, Section 1 of the WpHG
11.02.2019
Graefelfing, Munich (pta010/11.02.2019/10:33) - Release of Voting Rights Announcement
read more ...
PTA-AFR: Dr. Hönle AG: Pre-announcement of a financial report according to articles 114 - 117 WpHG
25.01.2019
Graefelfing (pta021/25.01.2019/14:38) - Dr. Hönle AG announces that the following financial reports shall be disclosed:
read more ...
PTA-News: Dr. Hönle AG: Operating result of the Hönle Group surges to Euro 30.7 million
14.12.2018
Gräfelfing/München (pta005/14.12.2018/07:40) - According to preliminary figures, Hönle Group generated sales of TEur126,492 in the 2017/2018 financial year, which corresponds to an increase of 24.1% compared to the previous year. The operating result (EBIT) jumped by 101.8% to...
read more ...
PTA-News: Dr. Hönle AG: Dr. Hönle AG is included in SDAX
06.09.2018
Gräfelfing/München (pta033/06.09.2018/16:50) - Dr. Hönle AG, an innovative technology company located in Gräfelfing near Munich, will be included in the SDAX. Deutsche Börse has passed extensive rule changes for the indices DAX, MDAX, SDAX and TecDAX. As part of this new regulation...
read more ...
PTA-News: Dr. Hönle AG: Operating result surges by 132% to Euro 19.9 million
10.08.2018
Gräfelfing/München (pta006/10.08.2018/08:10) - In the first nine months of financial year 2017/2018, the Hönle Group generated sales revenues of TEur88,750, representing a 23.2% increase year-on-year. The operating result (EBIT) jumped by 132.0% to TEur19,865 in the current financial...
read more ...
PTA-DD: Dr. Hönle AG: Managers' transactions announcement according to article 19 MAR
13.06.2018
Graefelfing, Munich (pta031/13.06.2018/15:33) - Announcement
read more ...
PTA-News: Dr. Hönle AG: Operating result surges by 168 % to Euro 15.0 million
18.05.2018
Graefelfing/Munich (pta007/18.05.2018/07:30) - The Hönle Group's sales revenues increased by 28.5 % to TEur 60,671 in the first six months of the 2017/2018 financial year. The operating result surged by 167.6 % to TEur 15,047 due to the high proportion of adhesive revenues. Revenues...
read more ...
PTA-PVR : Dr. Hönle AG: Release according to Article 40, Section 1 of the WpHG
28.03.2018
Gräfelfing/München (pta027/28.03.2018/21:00) - Release of Voting Rights Announcement
read more ...
PTA-PVR : Dr. Hönle AG: Release according to Article 40, Section 1 of the WpHG
28.03.2018
Gräfelfing/München (pta028/28.03.2018/21:00) - Release of Voting Rights Announcement
read more ...
PTA-PVR : Dr. Hönle AG: Release according to Article 40, Section 1 of the WpHG
28.03.2018
Gräfelfing/München (pta020/28.03.2018/14:00) - Release of Voting Rights Announcement
read more ...
PTA-PVR : Dr. Hönle AG: Release according to Article 40, Section 1 of the WpHG
22.03.2018
Graefelfing, Munich (pta033/22.03.2018/18:49) - Release of Voting Rights Announcement
read more ...
PTA-News: Dr. Hönle AG: Hönle reports a great leap in earnings in the first quarter
22.02.2018
Gräfelfing/München (pta010/22.02.2018/08:05) - In the first quarter of financial year 2017/2018, the Hönle Group generated revenues of TEur 29,535, which corresponds to a 33.2 % year-on-year increase. The operating result (EBIT) jumped by 231.8 % to TEur 7,392 in the current financial...
read more ...
PTA-AFR: Dr. Hönle AG: Pre-announcement of a financial report according to articles 114, 115, 116 WpHG
29.01.2018
Graefelfing, Munich (pta029/29.01.2018/14:08) - Dr. Hönle AG announces that the following financial reports shall be disclosed:
read more ...
PTA-News: Dr. Hönle AG: Hönle Group increases consolidated result by 26 %
15.12.2017
Graefelfing, Munich (pta006/15.12.2017/08:05) - Preliminary figures indicate a 9.1 % rise in Hönle Group's revenues to TEur 101,926 in the financial year 2016/2017. The operating result (EBIT) improved by 22.6 % to TEur 15,207. Earnings before taxes climbed by 23.5 % to TEur 14,877 and...
read more ...
PTA-DD: Dr. Hönle AG: Managers' transactions announcement according to article 19 MAR
08.11.2017
Graefelfing, Munich (pta033/08.11.2017/15:50) - Announcement
read more ...
PTA-PVR : Dr. Hönle AG: Release according to Article 26, Section 1 of the WpHG
04.10.2017
Gräfelfing/München (pta036/04.10.2017/16:42) - Release of Voting Rights Announcement
read more ...
PTA-PVR : Dr. Hönle AG: Release according to Article 26, Section 1 of the WpHG
18.09.2017
Graefelfing, Munich (pta016/18.09.2017/10:50) - Release of Voting Rights Announcement
read more ...
PTA-News: Dr. Hönle AG: Hönle Group increases sales by 4.8% to Euro 72 million in the first nine months
17.08.2017
Gräfelfing, Munich (pta011/17.08.2017/07:40) - In the first nine months of the 2016/2017 financial year, the Hönle Group generated revenue of Eur72,052 thousand or an increase of 4.8% compared to the previous year's period. The operating result (EBIT) came to Eur8,564 thousand, which is...
read more ...
PTA-News: Dr. Hönle AG: Hönle Group increases its operating result by 5,2% to Euro 5.6 million in the first half of the year
19.05.2017
Gräfelfing/München (pta007/19.05.2017/06:55) - In the first six months of the 2016/2017 financial year, revenue generated by the Hönle Group increased by 5.4% to Eur47,228 thousand. Revenue in the first quarter was down on the previous year due to the relocation of a production site of...
read more ...
PTA-PVR : Dr. Hönle AG: Release according to Article 26, Section 1 of the WpHG
13.04.2017
Graefelfing, Munich (pta036/13.04.2017/16:25) - Release of Voting Rights Announcement
read more ...
PTA-PVR : Dr. Hönle AG: Release according to Article 26, Section 1 of the WpHG
13.04.2017
Graefelfing, Munich (pta038/13.04.2017/16:25) - Release of Voting Rights Announcement
read more ...
PTA-PVR : Dr. Hönle AG: Release according to Article 26, Section 1 of the WpHG
29.03.2017
Graefelfing, Munich (pta028/29.03.2017/14:45) - Release of Voting Rights Announcement
read more ...
PTA-PVR : Dr. Hönle AG: Release according to Article 26, Section 1 of the WpHG
29.03.2017
Graefelfing, Munich (pta030/29.03.2017/14:45) - Release of Voting Rights Announcement
read more ...
PTA-News: Dr. Hönle AG: Hönle generates operating result of Euro 2.2 million in Q1 and expects jump in earnings in HY2
22.02.2017
Gräfelfing/München (pta007/22.02.2017/07:25) - In the first quarter of financial year 2016/2017, the Hönle Group generated sales revenues of TEur 22,180, which corresponds to a 2.0 % decrease year-on-year. The operating result (EBIT) of TEur 2,228 was below the prior-year's figure of...
read more ...
Adhoc Release
PTA-Adhoc: Dr. Hönle AG: Adjustment of the outlook for the 2023/24 financial year
30.04.2024
Gilching (pta002/30.04.2024/00:40) - As communicated in the last capital market statement, the Management Board continues to assume that there will be an upturn in business activities in the second half of the financial year. However, the increase in sales and earnings will be weaker than...
read more ...
PTA-Adhoc: Dr. Hönle AG: Hönle Group expects a decline in sales and earnings in Q1 and confirms outlook for the financial year
09.02.2024
Gilching (pta007/09.02.2024/08:30) - The Hönle Group achieved lower sales and results in the first three months of the 2023/2024 financial year compared to the period of the previous year due to the weak market environment in machinery and plant engineering as well as order delays.
read more ...
PTA-Adhoc: Dr. Hönle AG: Hönle Group adjusts forecast for the 2022/2023 FY and provides outlook on the 2023/2024 FY
05.12.2023
Gilching (pta044/05.12.2023/20:00) - The Management Board expected for the Hönle Group, sales of €100 million to €105 million, an adjusted operating result (EBIT adjusted) of €5.5 million to €6.5 million and an operating result (EBIT ) between €7 million and €8 million in the...
read more ...
PTA-Adhoc: Dr. Hönle AG: Dr. Markus Arendt becomes Managing Director of Dr. Hönle AG
20.10.2023
Gilching (pta022/20.10.2023/17:35) - The Supervisory Board of Dr. Hönle AG intends to appoint Dr. Markus Arendt as a member of the Management Board of Dr. Hönle AG with effect presumably from May 1st, 2024. He will follow Dr. Franz Richter, who was delegated to the Management Board by...
read more ...
PTA-Adhoc: Dr. Hönle AG: Reassessment of the business situation and adjustment of the outlook for the 2022/2023 financial year
01.06.2023
Gilching (pta049/01.06.2023/21:45) - After change of the CEO/CFO the Management Board of Dr. Hönle AG has analysed intensively all segments and business areas of the Hönle Group in recent weeks.
read more ...
PTA-Adhoc: Dr. Hönle AG: Dr. Franz Richter becomes CEO of Dr. Hönle AG
25.04.2023
Gilching (pta044/25.04.2023/23:20) - The Supervisory Board of Dr. Hönle AG delegates Dr. Franz Richter, who currently holds the position of Chairman of the Supervisory Board of Dr. Hönle AG, as the successor to the Chairman of the Management Board, Mr. Norbert Haimerl, who is resigning...
read more ...
PTA-Adhoc: Dr. Hönle AG: Hönle Group generates operating result of € 2.7 million in the first quarter and confirms the annual forecast
20.02.2023
Gilching (pta038/20.02.2023/16:05) - According to preliminary figures, Hönle Group's sales revenues in the first three months of financial year 2022/2023 came to € 30.6 million and were thus 8.4% down from the previous year's level. Sales generated with air disinfection equipment, in...
read more ...
PTA-Adhoc: Dr. Hönle AG: Special effects weigh on earnings in the 2021/2022 financial year
21.12.2022
Gilching (pta033/21.12.2022/16:40) - According to preliminary figures, Hönle Group was able to increase its sales in the 2021/2022 financial year by 9.9% to € 126.5 million compared to the previous year.
read more ...
PTA-Adhoc: Dr. Hönle AG: Hönle sells all shares in Raesch Quarz (Germany) GmbH, Ilmenau
12.12.2022
Gilching (pta024/12.12.2022/15:10) - As already announced on November 2, 2022, the Executive Board of Dr. Hönle AG decided to close the subsidiary Raesch Quarz (Germany) GmbH, Ilmenau, and to sell all the assets. Fortunately, an agreement has now been reached on the sale of the entire...
read more ...
PTA-Adhoc: Dr. Hönle AG: Declining market for air sterilization devices leads to impairment of inventories at Hönle
02.12.2022
Gilching (pta026/02.12.2022/15:35) - The corona pandemic led to massive demand for mobile air purification devices that were used to reduce the germ load and control the risk of infection. The use of mobile air cleaning devices in public education and training facilities was also...
read more ...
PTA-Adhoc: Dr. Hönle AG: Initiation of restructuring measures at Raesch Quarz (Germany) GmbH, Ilmenau
02.11.2022
Gilching (pta016/02.11.2022/10:30) - The supervisory board of Dr. Hönle AG today approved the Management Board's proposal to initiate restructuring measures at the subsidiary Raesch Quartz (Germany) GmbH, Ilmenau, while safeguarding the rights of the bodies responsible for operational...
read more ...
PTA-Adhoc: Dr. Hönle AG: Norbert Haimerl becomes CEO of Dr. Hönle AG
23.08.2022
Gilching (pta034/23.08.2022/16:30) - The supervisory board of Dr. Hönle AG has decided to fill the position of CEO, which was newly created in the course of the restructuring of the Management Board, with Management Board member Norbert Haimerl. Mr. Haimerl will assume the position of CEO...
read more ...
PTA-Adhoc: Dr. Hönle AG: Hönle achieves an operating result of € 7.2 million in the 9-month period
29.07.2022
Gilching (pta042/29.07.2022/14:20) - Earnings in the third quarter were worse than planned. The situation on procurement markets and the increase in energy prices burden on quarterly earnings heavily. In addition, one-time effects affected the result. These are largely related to the...
read more ...
PTA-Adhoc: Dr. Hönle AG: Dr. Hönle AG adjusts outlook for 2021/2022 financial year
22.07.2022
Gilching (pta028/22.07.2022/14:55) - Business development in the third quarter and especially in June 2022 was significantly worse than planned. The situation on procurement markets and the sharp increase in energy prices temporarily burden heavily on the Hönle Group's earnings. In...
read more ...
PTA-Adhoc: Dr. Hönle AG: Dr. Hönle AG puts annual forecast into concrete terms
18.02.2022
Gilching (pta012/18.02.2022/09:40) - The Management Board expects revenues of between € 130 and € 140 for the Hoenle Group and an operating result (EBIT) of between € 14 and € 17 million in financial year 2021/2022.
read more ...
PTA-Adhoc: Dr. Hönle AG: Hönle Group generates adjusted operating profit of EUR 7.9 million
01.12.2021
Gilching (pta032/01.12.2021/14:55) - The Hönle Group benefited from the economic upturn and was able to significantly increase its sales and, above all, its incoming orders. In addition, the new group companies made a significant contribution to the expansion of business activities....
read more ...
PTA-Adhoc: Dr. Hönle AG: Hönle takes non-cash impairment into account in the 2020/2021 financial year – outlook remains positive
24.11.2021
Gilching (pta040/24.11.2021/18:30) - The assumptions made as part of the planning and now adjusted for the business development of a subsidiary of Dr. Hönle AG leads to non-cash impairment losses in the group in the fourth quarter. The impairments relate to goodwill in the amount of 3.4...
read more ...
PTA-Adhoc: Dr. Hönle AG: Hönle adjusts outlook for the past financial year and gives outlook for the new financial year
06.10.2021
Gilching (pta029/06.10.2021/17:20) - The move of the Dr. Hönle AG in the new company building resulted in less production and delivery than planned in the fourth quarter. In addition, long delivery times for electronic components, mechanical components and, in some cases, raw materials at...
read more ...
PTA-Adhoc: Dr. Hönle AG: The promotion of mobile air disinfection systems provides excellent growth opportunities for Hönle
15.07.2021
Gräfelfing/München (pta029/15.07.2021/14:40) - According to preliminary figures, Hönle Group sales revenues increased from Eur 71.7 million to Eur 84.9 million in the nine-month period. The operating result (EBIT) climbed from Eur 6.3 million to Eur 7.3 million. Adverse effects weighted...
read more ...
PTA-Adhoc: Dr. Hönle AG: Dr. Hönle AG acquires UV-Technik Meyer GmbH
15.09.2020
Gräfelfing/München (pta025/15.09.2020/14:00) - Dr. Hönle AG acquires 100% of the shares of UV-Technik Meyer GmbH based in Ortenberg (Hesse).
read more ...
PTA-Adhoc: Dr. Hönle AG: Dr. Hönle AG wins new strategic investor for growth financing
21.08.2020
Graefelfing, Munich (pta021/21.08.2020/12:55) - With Peter Möhrle Holding, the family office of the Peter Möhrle entrepreneur family, Dr. Hönle AG wins a new strategic investor for Hönle Group's growth financing.
read more ...
PTA-Adhoc: Dr. Hönle AG: Hönle acquires Disinfection Specialist, STERILSYSTEMS
17.08.2020
Gräfelfing/München (pta023/17.08.2020/12:50) - Dr. Hönle AG acquires STERILSYSTEMS GmbH. The Hönle Group is thus significantly expanding its activities in the life science sector. As a result of the pandemic, sensitivity to and global demand for disinfection solutions has risen...
read more ...
PTA-Adhoc: Dr. Hönle AG: Hönle withdraws forecast due to the Covid-19 pandemic
27.04.2020
Graefelfing, Munich (pta021/27.04.2020/11:30) - The managing board of Dr. Hönle AG today decided to withdraw the outlook for the 2019/2020 financial year. The impact of the Covid-19 pandemic on the business development of the Hönle Group cannot be estimated currently.
read more ...
PTA-Adhoc: Dr. Hönle AG: Hönle Group generates operating profit of Euro 17 million
04.12.2019
Gräfelfing, München (pta029/04.12.2019/15:10) - According to preliminary figures, the Hönle Group's revenue in the financial year 2018/2019 was TEur107,747, which is 14.8% below the previous year's figure. The operating result (EBIT) decreased from TEur30,687 to TEur17,003, which...
read more ...
PTA-Adhoc: Dr. Hönle AG: Hönle Adjusts Forecast
31.07.2019
Gräfelfing/München (pta042/31.07.2019/18:30) - The Management Board assumes that the Hönle Group will achieve sales of Eur 105 to 110 million and an operating result of Eur 17 to 19 million in the 2018/2019 financial year. Previously, the Management Board had assumed to achieve the...
read more ...
PTA-Adhoc: Dr. Hönle AG: Hönle Specifies Forecast
26.04.2019
Gräfelfing/München (pta021/26.04.2019/10:50) - The Management Board expects the Hönle Group to reach the lower end of the previously communicated target corridor of Eur 115 to Eur 130 million in revenue and Eur 22 to Eur 30 million in operating profit in the 2018/2019 financial year.
read more ...
PTA-Adhoc: Dr. Hönle AG: Hönle increases its profit forecast
09.11.2018
Gräfelfing/München (pta024/09.11.2018/12:16) - The Hönle Group again raises its forecast for financial year 2017/2018, expecting an operating result (EBIT) of between Eur 30.5 million and Eur 31.5 million instead of the initially projected Eur 26 to Eur 30 million. In financial year...
read more ...
PTA-Adhoc: Dr. Hönle AG: Hönle increases its profit forecast
09.11.2018
Graefelfing, Munich (pta021/09.11.2018/11:20) - The Hönle Group again raises its forecast for financial year 2017/2018, expecting an operating result (EBIT) of between Eur 30.5 million and Eur 31.5 million instead of the initially projected Eur 26 to Eur 30 million. In financial year...
read more ...
PTA-Adhoc: Dr. Hönle AG: Hönle increases its profit forecast to between Euro 26 and 30 million
20.06.2018
Gräfelfing/München (pta030/20.06.2018/16:00) - The Hönle Group expects strong business development, especially in the adhesives segment, and therefore raises its forecast for the 2017/2018 financial year again. Instead of sales of between Eur 115 and 125 million, now sales of between...
read more ...
PTA-Adhoc: Dr. Hönle AG: Hönle increases its profit forecast to between Euro 22 and 26 million
04.12.2017
Gräfelfing/München (pta026/04.12.2017/15:30) - The Hönle Group increases its profit forecast (EBIT) for the financial year 2017/2018 from between Eur16 and 18 million to between Eur22 and 26 million. This considerable increase in profit is due to an anticipated strong development of the...
read more ...
PTA-Adhoc: Dr. Hönle AG: Hönle expects operating result of Euro 12 to 13 million
28.07.2016
Gräfelfing/Munich (pta022/28.07.2016/16:37) - The Hönle Group reduces its expectations for the current financial year. Revenues in the 2015/2016 financial year are expected to amount to Eur 90 to 92 million and the operating result will probably come to between Eur 12 and 13 million....
read more ...
PTA-Adhoc: Dr. Hönle AG: Joint Venture of Honle Group with SKC Co. Ltd.
20.05.2015
Gräfelfing/München (pta025/20.05.2015/17:07) - The Dr. Hönle AG subsidiary, Panacol Elosol GmbH, concluded today a cooperation agreement with SKC Co. Ltd.. The agreement expresses the mutual will of both parties to establish a joint enterprise in Korea with a view to selling and...
read more ...
PTA-Adhoc: Dr. Hönle AG: Hönle generates operating result of Eur 7.7 million in financial year 2012/2013
09.12.2013
Graefelfing/Munich (pta019/09.12.2013/12:20) - According to preliminary figures, the Hönle Group earned revenues of Eur 77.3 million (PY: Eur 72.1 million) in the financial year 2012/2013. The operating result (EBIT) came to Eur 7.7 million (PY: Eur 8.3 million). As reported in the...
read more ...
PTA-Adhoc: Dr. Hönle AG: Changes in accounting impact positively on the Hönle Group's financial result
26.11.2013
Gräfelfing, Munich (pta023/26.11.2013/12:50) - A special effect resulting from accounting changes impacts positively on Hönle Group's financial result in the 2012/2013 financial year.
read more ...